πŸ‡ΊπŸ‡Έ FDA
Patent

US 9393203

Osmotic drug delivery system

granted A61KA61K31/192A61K31/557

Quick answer

US patent 9393203 (Osmotic drug delivery system) held by Supernus Pharmaceuticals, Inc. expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/192, A61K31/557, A61K31/5575, A61K31/5585